blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4288523

EP4288523 - GENETICALLY ENGINEERED BACTERIUM FOR HANGOVER AND LIVER DISEASE PREVENTION AND/OR TREATMENT [Right-click to bookmark this link]
Former [2023/50]GENETICALLY GENGINEERED BACTERIUM FOR HANGOVER AND LIVER DISEASE PREVENTION AND/OR TREATMENT
[2023/52]
StatusThe application has been withdrawn
Status updated on  07.06.2024
Database last updated on 25.09.2024
FormerRequest for examination was made
Status updated on  10.11.2023
FormerThe international publication has been made
Status updated on  12.08.2022
Most recent event   Tooltip07.06.2024Withdrawal of applicationpublished on 10.07.2024  [2024/28]
Applicant(s)For all designated states
Commbio Therapeutics Co., Ltd.
Room 602/603, Building 1, No. 720 Cailun Road
Pudong New Area
Shanghai 201203 / CN
[2023/50]
Inventor(s)01 / XIANG, Bin
Shanghai 201203 / CN
02 / YIN, Shengming
Shanghai 201203 / CN
03 / WANG, Yanning
Shanghai 201203 / CN
 [2023/50]
Representative(s)Pestalozzi, Deborah
Isler & Pedrazzini AG
Giesshübelstrasse 45
Postfach 1772
8027 Zürich / CH
[2023/50]
Application number, filing date22749257.608.02.2022
[2023/50]
WO2022CN75470
Priority number, dateWO2021CN7610208.02.2021         Original published format: PCT/CN2021/076102
[2023/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022166978
Date:11.08.2022
Language:EN
[2022/32]
Type: A1 Application with search report 
No.:EP4288523
Date:13.12.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 11.08.2022 takes the place of the publication of the European patent application.
[2023/50]
Search report(s)International search report - published on:CN11.08.2022
ClassificationIPC:C12N1/21, C12N15/70, C12N15/53, A23C9/13, A61K35/741, A61K38/44, A61P25/32, A61P1/16, C12R1/19
[2023/50]
CPC:
C12Y102/0101 (EP,CN,KR,US); C12N15/70 (EP,CN,KR); C12N9/0008 (EP,CN,KR,US);
A61K35/741 (EP,CN,KR,US); A23C9/13 (CN); A23L33/135 (EP,CN,KR,US);
A61K38/44 (CN,KR); A61P1/16 (CN,KR); A61P25/32 (CN,KR);
A23C9/1203 (EP); A23V2002/00 (CN); A61K2035/115 (EP,US);
C12N2800/22 (CN,KR); C12R2001/19 (EP); Y02A50/30 (EP) (-)
C-Set:
A23V2002/00, A23V2200/334, A23V2200/30 (CN)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/50]
TitleGerman:GENETISCH MANIPULIERTES BAKTERIUM FÜR KATER UND PRÄVENTION UND/ODER BEHANDLUNG VON LEBERERKRANKUNGEN[2023/50]
English:GENETICALLY ENGINEERED BACTERIUM FOR HANGOVER AND LIVER DISEASE PREVENTION AND/OR TREATMENT[2023/52]
French:BACTÉRIE GÉNÉTIQUEMENT MODIFIÉE POUR LA PRÉVENTION ET/OU LE TRAITEMENT DE LA GUEULE DE BOIS ET DE LA MALADIE DU FOIE[2023/50]
Former [2023/50]GENETICALLY GENGINEERED BACTERIUM FOR HANGOVER AND LIVER DISEASE PREVENTION AND/OR TREATMENT
Entry into regional phase08.09.2023National basic fee paid 
08.09.2023Search fee paid 
08.09.2023Designation fee(s) paid 
08.09.2023Examination fee paid 
Examination procedure08.09.2023Examination requested  [2023/50]
10.11.2023Amendment by applicant (claims and/or description)
03.06.2024Application withdrawn by applicant  [2024/28]
Fees paidRenewal fee
12.02.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]CN101985625  (UNIV NANJING AGRICULTURAL) [A] 1-54 * see the whole document *;
 [A]CN110734890  (SHANDONG HANTAI BIOTECHNOLOGY CO LTD) [A] 1-54 * see the whole document *;
 [A]CN110951660  (UNIV JIANGNAN) [A] 1-54 * see the whole document *;
 [X]CN111565733  (ZBIOTICS COMPANY) [X] 1-54 * see claims 1-62，SEQ ID NO:4，description，paragraphs[0081]-[0082] *;
 [PX]CN113186140  (COMMBIO THERAPEUTICS CO LTD) [PX] 1-54 * see claims 1-54 *;
 [A]  - He Chongxin, Xu Zhengjie, Pan Qin, "Effect of high-fat diet or high-fructose diet on endogenous ethanol and hepatic ethanol metabolic enzymes in rats", JOURNAL OF PRACTICAL HEPATOLOGY, (20160701), vol. 19, no. 4, doi:10.3969/j.issn.1672-5069.2016.04.009, ISSN 1672-5069, pages 418 - 422, XP055956744 [A] 1-54 * pages 418-422，see the whole document *

DOI:   http://dx.doi.org/10.3969/j.issn.1672-5069.2016.04.009
by applicantUS2019076489
    - BATZER et al., Nucleic Acid Res., (19910000), vol. 19, page 5081
    - OHTSUKA et al., J. Biol. Chem., (19850000), vol. 260, pages 2605 - 2608
    - ROSSOLINI et al., Mol. Cell. Probes, (19940000), vol. 8, pages 91 - 98
    - ALTSCHUL S.F et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 410
    - STEPHEN F. et al., Nucleic Acids Res., (19970000), vol. 25, pages 3389 - 3402
    - HIGGINS D.G et al., Methods in Enzymology, (19960000), vol. 266, pages 383 - 402
    - LARKIN M.A. et al., Bioinformatics (Oxford, England, (20070000), vol. 23, no. 21, pages 2947 - 8
    - CHAUDHRY KK et al., Alcoholism, clinical and experimental research, (20150000), vol. 39, pages 1465 - 75
    - PUROHIT VET, Hepatology (Baltimore, Md)., (20060000), vol. 43, pages 872 - 8
    - GUO et al., Clinical and Experimental Pharmacology and Physiology, (20090000), vol. 36, pages 463 - 8
    - AGARWAL, Pathol Biol (Paris)., (20011100), vol. 49, no. 9, pages 703 - 9
    - RAMCHANDANI et al., Pathol Biol (Paris), (20011100), vol. 49, no. 9, pages 676 - 82
    - VASILIOU et al., Pharmacology, (20000900), vol. 61, no. 3, pages 192 - 8
    - YOSHIDA, Pharmacogenetics, (19920800), vol. 2, no. 4, pages 139 - 47
    - HIGUCHI S et al., The Lancet, (19940000), vol. 343, pages 741 - 2
    - XIAO JET, Journal of hepatology, vol. 71, pages 212 - 21
    - FAN J-G, Journal of Gastroenterology and Hepatology, (20130000), vol. 28, pages 11 - 7
    - REHM JET, The Lancet, (20090000), vol. 373, pages 2223 - 33
    - SZABO G et al., Hepatology (Baltimore, Md)., (20190000), vol. 69, pages 2271 - 83
    - BAKER et al., PLOS One, vol. 5
    - ZHU et al., Hepatology, (20130200), vol. 57, no. 2, pages 601 - 9
    - CANFORA et al., Nat Rev Endocrinol., (20190500), vol. 15, no. 5, pages 261 - 273
    - YUAN et al., Cell Metabolism, (20190000), vol. 30, pages 675 688 - 688
    - LI et al., Toxicological sciences: an official journal of the Society of Toxicology, (20180000), vol. 164, pages 428 - 38
    - DOORN et al., Chemical research in toxicology, (20060000), vol. 19, pages 102 - 10
    - ZHU et al., Hepatology, (20130000), vol. 57, no. 2, pages 601 - 609
    - FRANTZ JC et al., JBacteriol, (19790000), vol. 137, pages 1263 - 1270
    - AMARETTI A et al., Appl Environ Microbiol, (20070000), vol. 73, pages 3637 - 364
    - WEIMER PJ et al., Appl Environ Microbiol, (19770000), vol. 33, pages 289 - 297
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.